Home
Live Updates
FDA Approves Macitentan, Tadalafil Combination Tablet for PAH : vimarsana.com
FDA Approves Macitentan, Tadalafil Combination Tablet for PAH
The combination tablet (Opsynvi; Johnson & Johnson) can also be used for individuals with pulmonary arterial hypertension who are being treated with stable doses of macitentan and tadalafil as separate tables.
Related Keywords
,
Kelly Chin ,
Pulmonary Hypertension Program ,
Ut Southwestern Medical Center ,
Johnson ,
Internal Medicine ,
Medical Center ,
Clinical Study ,
Corresponding Fixed Dose Combination Therapy ,
Subjects With Pulmonary Arterial Hypertension ,
Macitentan Containing Products Risk Evaluation ,
Mitigation Strategy ,
vimarsana.com © 2020. All Rights Reserved.